Just the Facts: Tryptamine Therapeutics doses first patient in obesity-focused psilocin study

How Tryptamine Therapeutics (ASX:TYP) is accelerating innovative psychedelic therapiesПодробнее

Webinar: Tryp Therapeutics: Leading the next wave of psychedelic drugs beyond mental healthПодробнее

METFORMIN as WEIGHT LOSS pill? True?Подробнее

Robert Lustig, MD:Ozempic vs. Rimonabant: A Weight Loss Showdown #Shorts #ozempic #ozempicweightlossПодробнее

What happens to fat when you lose weight is pretty wild.Подробнее

How Psilocybin Can Rewire Our Brain, Its Therapeutic Benefits & Its Risks | Huberman Lab PodcastПодробнее

Ozempic is a game-changer. Here’s how it works.Подробнее

Unlocking the Power of IV Psilocin: A Game-Changing Interview with Jim Gilligan of Tryp TherapeuticsПодробнее

Tryp Therapeutics discusses unique approach to psychedelic treatment study of binge eatingПодробнее

Tryp Therapeutics talks next steps after IND submission to treat eating disorders with psilocybinПодробнее

How much weight can you lose with Mounjaro? 🤷🏻‍♂️👨🏻‍⚕️ #mounjaro #doctor #obesityПодробнее

Tryp Therapeutics Inc. (OTCQB: TRYPF | CSE: TRYP): Virtual Investor ConferencesПодробнее

Microdosing Psilocybin - Is it Worth the Trip? Doctor's AnalysisПодробнее

A Promising New Obesity DrugПодробнее

Could SHROOMS Solve OBESITY!?Подробнее

The Expanding Obesity Revolution: New OptionsПодробнее

Prescribing The Right Anti-Obesity Drug for Every PatientПодробнее

Diabetes Overweight MythПодробнее